Preprint
Review

Review: Biocomposite Scaffolds for Tissue Engineering: Materials, Fabrication Techniques and Future Directions

Altmetrics

Downloads

76

Views

66

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

25 October 2024

Posted:

28 October 2024

You are already at the latest version

Alerts
Abstract

Tissue engineering is an interdisciplinary field that combines methods, materials, and biological molecules to fabricate newly formed tissues to replace or restore functional organs. Biomaterials-based scaffolds play a vital role in developing new tissue by interacting with human cells. Tissue Engineering scaffolds with ideal characteristics, namely, nontoxicity, biodegradability, and appropriate mechanical and surface properties, are vital for tissue regeneration applications. Although commonly utilized biomaterials can provide physical and chemical properties needed for tissue regeneration, inadequate biomimetic properties, as well as insufficient interactions of cells-scaffolds interaction, still need to be improved for the application of tissue engineering in vivo. Consequently, developing innovative biomaterials-based stimulus-responsive 3D scaffolds that can enhance the mediators of cell adhesion and cellular functioning and that can form functional tissues by providing structural integrity within an appropriate time is much needed. It is possible to achieve some essential features using a single material, so combining two or more materials may fulfill the requirements. In order to achieve a proper scaffold design, a suitable fabrication technique and combination of biomaterials with controlled micro or nanostructures are needed to achieve the proper biological responses. This review highlights the natural polymers, smart materials, and recent advanced techniques currently used to create emerging scaffolds for tissue regeneration applications.

Keywords: 
Subject: Chemistry and Materials Science  -   Biomaterials

1. Introduction

The study of tissue engineering (TE) scaffold is an important field that researchers have studied to determine if it is a less invasive and effective treatment for regenerative medicine. The cellular process of the TE scaffold technique involves inserting a non-toxic component into the body, known as the scaffold, through which the cells can attach, migrate, differentiate, and proliferate. Biocompatible materials that mimic the cellular structure and function of diseased or damaged tissues have been widely studied in tissue engineering. Secretion of the natural extracellular matrix (ECM) takes place to regenerate the damaged tissue when the surrounding tissue absorbs the biocompatible materials. Most cell types can attach to the ECM, and this event aims to fabricate TE scaffolds from biodegradable and biocompatible polymers. Currently, there are obstacles to using biological substitutes to form tissue scaffolds. For this reason, it is essential to modify and fabricate an optimal tissue scaffold that is non-toxic and does not interfere with the immune system or cellular transporting mechanisms. When properly fabricated, biodegradable components have the potential to replace the ECM temporarily and have properties that can induce the biomolecule and/or drug release for anti-inflammatory and antibacterial activities in the tissue for regenerating.
Tissues play an essential role in organisms, and any damage to the tissues impairs the body's normal functioning and the quality of life of an organism. Although tissues such as bones and skeletal muscles can heal themselves after incurring some form of injury, clinical interventions are required to address severe injuries [1]. Under the circumstances, conventional treatment methods, including autografts or donor grafts, may not work effectively because they take longer to recover, have an increased risk of infection, or may be immunologically rejected [2]. As a result, TE is the most effective alternative to guarantee a patient's full recovery in case of severe tissue damage [3]. TE restores, improves, and maintains tissues that have been damaged due to injury or disability that arises from congenital conditions. This is achieved using natural and synthetic polymers.
Developing biocomposite scaffolds with appropriate properties is very important in TE. Regenerative medicine is an interdisciplinary field that applies life sciences and engineering principles to promote regeneration or restoration of injured tissues and organs. Using regenerative medicine, tissues and organs damaged through aging, trauma, or disease can be healed or even replaced [4]. Central to regenerative medicine is TE. TE is a field in which biological and engineering principles are employed to create new tissues and organs [5]. TE is required because it provides an alternative source of biocompatible and biodegradable tissues and organs, which addresses the crucial gap where there is a high demand for tissues and organs but a limited supply.
For TE to be functional, a strategy of regenerating tissues and organs, a triad of cells, scaffolds, and growth factors are usually employed (Figure 1). The goal is to either stimulate the original tissue to regenerate or replace the original tissue. A scaffold is used not only to provide a structure similar to that provided by an extracellular matrix but also to provide a framework where biological cues can be used, added, or infused to promote regeneration and mimic an environment found naturally in healthy tissues and organs.
The use of scaffolds in TE has evolved throughout history. Despite being constructed from varying materials, such as linen in Egypt, catgut in Europe, and ant heads in India and South Africa, these scaffolds provided a framework for a tissue to heal or regenerate. One common barrier faced by many pioneers in scaffold creation was constructing scaffolds that could not only provide a structural framework but also facilitate cell attachment, differentiation, and proliferation. The ideal scaffold must also allow for the crucial cell-to-cell and cell-to-matrix interactions demonstrated in vivo [6].
Scaffolds in TE are three-dimensional and porous, providing a favorable environment for tissue reparation and regeneration [7]. There are several requirements for scaffolds. The ideal scaffold should be biodegradable, biocompatible, possess mechanical properties, have a highly porous architecture, and be cost-effective. Cell adhesion and proliferation rely on the scaffold's biocompatibility. Furthermore, another measure of how biocompatible a scaffold is is an immune response. A negligible immune response is ideal for preventing chronic inflammatory reactions that impede healing or may even cause rejection [7].
This review comprehensively analyzes various biomaterials used to fabricate biocomposite scaffolds used in TE, focusing on their materials, fabrication techniques, and future directions. This chapter also aims to synthesize current knowledge on scaffold properties and their impact on tissue regeneration. By examining various materials and methods, the review seeks to identify the strengths and limitations of each approach, offering insights into potential advancements in scaffold technology. The scope of the review spans from foundational principles to the latest innovations to ensure a thorough understanding of the field's current state and future possibilities.

2. Natural, Synthetic, and Composite Materials Are Used to Fabricate TE Scaffolds

The primary natural polymers in TE scaffolds include chitosan, collagen, and chitin. Collagen forms part of the extracellular matrix in most connective tissues within the body of mammals. Generally, it is composed of fibrous protein [8]. Since it has a fibrillar structure, collagen plays an essential role in maintaining the biological structure and integrity of the extracellular matrix, thus providing support for tissues [9]. Furthermore, collagen is less immunogenic, more permeable, biocompatible, biodegradable, and has a structural porosity. Unfortunately, collagen does not have the mechanical strength ideal for complex tissue engineering [10]. As a result, bioceramics, such as hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP), are used with collagen to fabricate composite scaffolds to improve strength [10]. Furthermore, β-TCP is essential in providing better osteoconductivity and accelerating the scaffold degradation rate for replacement with a newly formed tissue [10].
Gelatin is another natural polymer that is used in tissue engineering scaffolds. It is mainly a protein derived from collagen through hydrolysis [11]. Since it contains Arginylglycylaspartic acid (RGD), gelatin is highly biocompatible. Furthermore, the Arginylglycylaspartic acid found within the gelatin structure makes it easy for cells to attach, spread, and proliferate [12]. Since gelatin has poor mechanical properties, it cannot be directly used to treat bone defects. Instead, gelatin-based scaffolds are combined with other materials, including silica nanoparticles and polymer microparticles, to improve their mechanical strength [12].
Another crucial natural polymer employed in tissue engineering scaffolds is chitosan. Chitosan is made up of a linear polysaccharide, usually found in crustaceans, mollusks, and cuticles of insects [13]. Biologically compatible, degradable, adhesive, and renewable [14]. Furthermore, it contains free amino groups, which can be involved in protonation, thus making chitosan easy to modify using biochemical groups [13]. The protonation of amino groups makes it easy for chitosan to electrostatically interact with DNA, proteins, lipids, or any other negatively charged synthetic polymers [15]. Mechanical enhancers are used together with chitosan to improve its mechanical strength. Table 1 shows the commonly used natural polymers used to fabricate tissue engineering scaffolds.
Recently, another natural polymer, pectin, developed with chitosan, was explored in tissue engineering as a scaffolding material to regenerate bone and skin tissues (Table 2). Blending chitosan and pectin produces a polyelectrolyte complex that outcomes a new scaffold that has enhanced mechanical resistance, swelling capacity, porous microstructures, stabilized crosslinking, and biocompatibility [19].
Biodegradable polymer matrix nanocomposites are highly effective for bone tissue engineering [20]. These materials have regenerative capabilities as they were shown to stimulate the regeneration of bones and tissues. Surav et al. emphasized natural biopolymers because they are cost-effective, have high availability, cause low immune response, have negligible toxicity, and are biocompatible. Natural biopolymers such as Hyaluronic acid, elastin, alginate, collagen, gelatin, chitosan, and GAGs (glycosaminoglycans) are some of the natural polymers used in scaffolds for bone tissue engineering, and they are also the most researched [20].
Scaffolds can also be derived from synthetic origins. Synthetic scaffolds meet the inconsistency found in natural scaffolds, which tend to differ from batch to batch. Furthermore, the same ethical concerns about animal-derived scaffolds do not apply to synthetic ones. With synthetic scaffolds, there is room for modification, higher availability, and low costs. Polyglycolic acid (PGA) and polylactic acid (PLA) have been investigated extensively in bone tissue engineering [21]. After implantation, PGA scaffolds, made from a material with high crystallinity, also demonstrated controlled degradation with decreased mechanical strength. Osteoblasts have been shown to proliferate and calcify on PGA scaffolds. PLA scaffolds are known for their mechanical and thermal properties. In addition to being biocompatible, pure PGA scaffolds also allow for the expression of osteogenic bone markers and the formation of calcium nodules [21].
Poly(caprolactone) (PCL) is a semicrystalline biocompatible synthetic polymer. Due to their biocompatibility, superior rheological properties, and elasticity, PCL polymer has been fabricated into many forms, such as films, matrices, membranes, micro/nanoparticles, capsules, fibers, and reservoir devices for drug delivery purposes and tissue engineering. PCL has relatively low stiffness, limited cell affinity, and is hydrophobic by nature, thus restricting its range of clinical applications for bone tissue regeneration. One of the strategies to overcome this limitation is to combine PCL polymer with particles that have bioactive effects, such as nHA, biphasic calcium phosphate (BCP), and bioactive glasses [22]. Since adequate hydrophilic surface is essential for cell attachment and to control biological interactions between the materials, different surface modification techniques have been applied to the PCL fibers, such as plasma treatment, chemical treatment with sodium hydroxide, coating or adsorbing natural ECM proteins, and blending with biologically active molecules.
In plasma treatment, oxygen-containing groups such as gases (air, O2, NH3, SO2, CO2), organic compounds, or polarized groups (hydroxyl, carboxyl, amino, and sulfate) are introduced on the fiber's surface. A previous study reported the influence on the biological interactions of the fiber after undergoing plasma treatment. Prabhakaran et al. observed that the PCL fibers exhibited higher proliferation of Schwann cells than the PCL and PCL–collagen fibers without the treatment [23]. As for the chemical treatment technique, sodium hydroxide (NaOH) is commonly used on PCL fibers. The carboxylate and hydroxyl groups are introduced to improve the wettability of PCL.
Another surface modification technique practiced for PCL fibers is the coating using protein adsorption to promote cell interaction. Protein, laminin, gelatin, collagen vitronectin, and fibronectin can provide signaling cues and adhesion ligands for cell functions. Koh et al. used laminin to promote neurite outgrowth and adsorbed onto the surface of PCL fibers. Lastly, the blending technique of surface modification for PCL using biologically active materials has been reported to compensate for the lack of several biological properties of PCL, such as low mechanical properties and bioactivity.
Composite scaffolds contain a combination of biomaterials: biopolymers, bioceramics, degradable metals, or natural products. When creating scaffolds for TE naturally, a composite material, such as bone, is needed, and it is logical to utilize a composite scaffold for increased biomimicry and bioactivity [22]. Many materials are used in these composite scaffolds; Turnbull et al. outline polymers, hydrogels, metals, ceramics, and bio-glasses, to name a few [22]. These composite scaffolds demonstrate desirable mechanical properties and cell interactions. Furthermore, it has been concluded that ceramic and polymer composite scaffolds have the most success.
Each type of scaffold material offers distinct advantages and disadvantages in TE. Natural materials are ideal because of their biocompatibility, low toxicity, and ability to stimulate regeneration in a tissue [25]. However, a disadvantage is their inconsistency from batch to batch. Synthetic materials are more consistent and accessible to modify and may lack that intrinsic bioactivity seen in natural scaffolds. Composite scaffolds take the best features of both natural and synthetic scaffolds. However, manufacturing biocomposite scaffolds is complex and expensive [26]. One of the challenges in fabricating tissue engineering scaffolds is determining the appropriate properties for the scaffold, such as high porosity, orientation, high surface area, controlled degradation rate, good mechanical properties, and biocompatibility. The material selection is crucial to determine the most suitable degradation rates for the scaffold, as rapid or delayed degradation may disturb the regeneration process. Besides, composition plays a significant part in the properties of nanofibers. By combining materials, the nanofibers may have better hydrophilicity properties and degradation rates. In order to produce nanofiber scaffolds with good characteristics, the processing parameters of the characterization tool must be well understood.

3. Scaffold Fabrication Techniques

In addition to the material used in the scaffold, the scaffold fabrication method is also fundamental in tissue engineering [26]. Scaffold fabrication is the process 'by which scaffolds with a continuous, uninterrupted pore structure can be made' [27].
A traditional scaffold fabrication method is solvent casting, where a polymer solution is poured into a mold, and the solvent is evaporated to form a scaffold. This method allows the fabrication of the desired architecture [28]. Another traditional method is gas foaming, a method of fabrication of synthetic scaffolds that avoids solvents. In this method, a polymer is compressed under high temperatures and molded into a solid disc. This disc will be placed in a carbon dioxide chamber for several days. This process allows gas to infiltrate the polymer disc and create a porous structure. [29]. Thermally-induced phase separation (TIPS) and freeze drying are other promising techniques for fabricating scaffolds from natural or synthetic polymers [30]. Highly porous and interconnected composite scaffolds were fabricated using a freeze-drying technique. This technique effectively produces composite scaffolds due to the ability to incorporate bioactive materials or drugs (Figure 2).
3D printing and electrospinning are advanced methods of tissue scaffold fabrication. These techniques are believed to craft intricate scaffolds with enhanced characteristics compared to traditional methods [31]. 3D printing is an additive manufacturing (AM) technique for fabricating structures and complex geometries from three-dimensional (3D) model data. The process consists of printing successive layers of materials formed on each other. Despite allowing for a broader range of geometries, 3D-printed polymer scaffolds tend to have inferior mechanical properties compared to scaffolds fabricated through other methods. Electrospinning is a fabrication technique that uses an electric field to propel and spin a polymer solution into nanofibers on a substrate [31]. Electrospinning is valued as it creates structures with higher surface area-to-volume ratios, which is beneficial in tissue engineering [32]. Combining 3D printing and electrospinning when creating a scaffold can make structures superior to those when the methods are used alone. Figure 3 shows the morphology of the electrospun nanofibrous scaffold and the growth of human skin fibroblast (HSF) cells on the scaffold [33].
Considering the function of the scaffold to direct cellular behaviors such as proliferation, migration, and differentiation, there are a few requirements of the scaffold that must be met. These requirements discussed earlier, such as a porous structure, large pore sizes, and a uniform interconnectedness of the pores, can be met using nanotechnology. Nanotechnology can manipulate a scaffold at the atomic, molecular, and macromolecular levels [34]. In addition, the scaffold can be constructed using the specific geometrical and topological structures found in natural tissue. The use of nanotechnology in scaffolds has been connected to higher mechanical strength, porosity, and enhanced biocompatibility [34].
Advanced scaffold fabrication methods, such as 3D printing and electrospinning, have demonstrated higher efficacy and precision in replicating the geometries seen in tissue. While traditional methods, although quicker and more straightforward, lack the complexities required in a scaffold for biomimicry. Traditional methods, such as solvent casting and gas foaming, are still the most cost-effective since advanced methods require expensive equipment. Therefore, even though advanced methods for scaffolding are more capable of mimicking the complex structures found in vivo, the cost problem remains a significant barrier to their widespread adoption in tissue engineering [31]. With the current technologies developed to fabricate tissue-engineered scaffolds, selecting the fabrication technique is very important in designing scaffolds with specific morphological features and cell functions that can provide temporary support for the intended application. Different fabrication techniques have their advantages and disadvantages. Thus, a novel technique is needed to overcome their drawback. The electrospinning fabrication technique can fabricate a nanofiber scaffold with a structure similar to the natural ECM. Although this technique limits the scaffold to have only a 2D structure, the nanofiber is complemented with the mimicking feature of the ECM, thus enabling cell growth onto the scaffold. Research is now moving towards to fabricate 3D microstructure using this technique.
Table 3. Strategies in fabricating 3D nanofibers.
Table 3. Strategies in fabricating 3D nanofibers.
Methods Summary Reference
Increasing spinning time In this way, an electrospun fiber membrane with a certain thickness will be obtained, which can reach hundreds of microns and become a 3D fibrous structure, although these methods may take a long time (for example, from 20 min to 20 h) till it grows to a sufficient 3D structure); mat thickness increases by increased spinning times leading to 3D fibrous thickness. Besides, multilayered with different materials can be fabricated by sequential electrospinning and co-electrospinning. This method's advantages are that each layer's fiber diameter, composition, and porosity can be controlled. [35]
Assembly by post-processing of 2D electrospun fibrous structures Examples are folding, layer-by-layer electrospinning, sintering, mechanical expansion such as peeling off the thin film from the collector, and then bending/folding or stacking the fiber layers into a 3D fibrous structure like pipe or thick mat [36]
Direct assembly by an auxiliary factor Examples are a 3D template, liquid, and collector. In addition, 3D fiber structures can also be successfully obtained through modification of the collector, for example, substituting the conventional 2D flat collector with a 3D collecting template and using liquid collection and removing microparticles filled between nanofibers have been reported, although a subsequent treatment to dry the as-prepared 3D structures or handle with the porogen is usually needed. [37]
Self-assembly A rapid growth of 3D fibrous macro without any additional assistance. Examples are fibrous yarns or spongiform fiber stacks. [37]
Although 3D bioprinting has shown extensive application in biomedical and tissue engineering fields, due to its static and inert nature, which considers just the earlier state of the printed object, whereas 4D bioprinting, which is integrated with 3D bioprinting, where 'time' is integrated as the fourth dimension [38], in 4D bioprinting, biocompatible responsive cells or materials can change their functions with time depending on the imposed external stimulus, due to the development in printing stimulus-responsive materials, which can alter their shape or be able to restructure with cellular self-organization, 4D bioprinting has promising applications in tissue engineering and drug delivery. It was reported that 4D printing allows the fabrication of dynamic constructions that can change property, shape, and functionality over time in response to stimuli, leading to various novel innovations in the tissue engineering field. With intelligent biomaterials, biological components, and living cells, 3D constructs with 4D impacts have been applied to develop smart and dynamic cell-laden TE constructs such as cartilage, bone, and vascular systems. However, 4D bioprinting is a complex system that is facing several challenges that can be mitigated by multidisciplinary strategies to address the current issues for basic research in TE and regenerative medicine [39]. Geometrically complex and highly customized structures can be fabricated using 4D printing [40]. Recently, shape memory polymers (SMPs) have received much attention. SMPs are smart polymers that have the ability to maintain a temporary shape and return to their original shape when they are exposed to external stimuli, such as magnetic field, heat, light, and stress. Poly D, L-lactide-co-trimethylene carbonate (PDLLA-co-TMC) is an example of temperature-responsive amorphous SMP. The physically crosslinked SMPs are called thermoplastics; they include polycaprolactone (PCL), polylactic acid (PLA), and thermoplastic polyurethane (PU). Chemically crosslinked SMPs are called thermosetting; they include cyanate resin, epoxy resin, thermosetting PU, polystyrene, and polyimide. Currently, 4D bioprinting technology includes inkjet printing, fused deposition modeling (FDM), direct ink writing (DIW), digital light processing (DLP), stereolithography apparatus (SLA), selective laser sintering (SLS), and more [40]. Table 1 shows the recent research related to 4D bioprinting, which uses smart polymers for biomedical and TE applications.
SMPs Technique/Mechanisms Applications Reference
Poly (N-isopropyl acrylamide) hydrogel matrix with 0.8 wt% nano fibrillated cellulose (NFC) Biomimetic 4D printing.
Reversible shape changes in water of varying temperature
Composite hydrogel architectures were 4D bioprinted with localized, anisotropic swelling behavior that solves the inverse problem of designing the alignment patterns for prearranged target shapes generating complex three-dimensional morphologies for generating architectures for biomedical devices, tissue engineering, and soft robotics. [41]
Bistrips/patches based on a poly(N-isopropyl acrylamide)-based hydrogel Temperature-responsive swelling A potential route for the development of self-folding stimuli-responsive micro-devices for biomedical applications. [42]
Polylactic acid (PLA) and continuous carbon fiber-based
continuous fiber fiber-reinforced thermoplastic Composites (CFRTPCs)
Fused deposition modeling (FDM) Light structures in the field of aviation and aerospace and biomedical applications. [43]
Polybutylene succinate and polylactic acid (PBS/PLA) filament 4 D printed and the graphene oxide (GO) functionalized shape memory PBS/PLA scaffolds 4D printed PBS/PLA filament showed outstanding shape memory performance and demonstrated a promising prospect in the biomedical field. [44]
Semicrystalline thermoplastic PLA pellets and Fe3O4 nanoparticles Direct ink writing (DIW) Minimally invasive medicine, biomedical devices [45]
Polyethyleneimine (PEI); Hyaluronic acid; Gelatin; Human umbilical vein endothelial cells (HUVECs) 4D inkjet printing Tissue engineering [46]
Polyethylene glycol diacrylate (PEGDA) hydrogel Digital light processing (DLP) Cardiac tissue regeneration [47]
Thermoplastic polyurethane Selective laser sintering (SLS). The shape-recovered scaffold facilitated directional cell adhesion and stimulated cell proliferation. Bone tissue engineering [48]

4. Tissue-Engineered Product Applications

Researchers addressed the limitations of collagen (Col) hydrogels, which tend to have poor physicochemical and mechanical properties, by adding mesoporous bioactive glass nanoparticles. (mBGns) [32]. These Col–mBGn nanocomposite hydrogel scaffolds demonstrated excellent stability due to increased chemical bonding between collagen molecules. Furthermore, mechanical strength was increased, as the Col–mBGn hydrogel scaffolds had improved loading and stiffness compared to those without mBGns [32].
The influential role of mBGns in collagen scaffolds is further demonstrated by the seeding of mesenchymal stem cells. (MSCs) MSCs cultivated within the Col–mBGn hydrogels demonstrated viability and enhanced cytoskeleton extensions in hydrogels with mBGn added. In addition, while Col hydrogen demonstrated extreme shrinkage within a few days of culture, Col–mBGn hydrogels demonstrated no observable shrinkage over 21 days [32].
In one study, Alshammari et al. 2023 explored the relationship of scaffold pore architecture to bone tissue formation using mechanobiological modeling [34]. Two scaffold designs were used: IREG1 and REG. IREG1 (irregular pore architecture had larger pores, measuring 0.4 × 0.2 mm, while REG (regular pore architecture) had smaller pores, measuring 0.3 × 0.2 mm. In the earlier period of the study, the IREG1 scaffold resulted in more considerable bone growth, while in the later period, the REG scaffold resulted in more considerable bone growth than IREG1 [34]. These results suggest that scaffolds' design and pore architecture can significantly influence bone growth rates over time, highlighting the importance of tailoring scaffold designs for different phases of bone regeneration.
Researchers have used regenerative medicine strategies for decades to develop tissue-engineered vascular grafts (TEVG) [49]. The TEVG was developed by seeding tubular biodegradable polymeric scaffolds with autologous bone marrow-derived mononuclear cells. In the first-in-human study, the feasibility of TEVGs was demonstrated as the TEVG transformed into a living vascular graft that could grow. However, this initial clinical trial revealed a high incidence of early TEVG stenosis, preventing this promising technology's widespread use [49]. Researchers have used mouse and computational models to address this complication and design strategies to inhibit stenosis. Recently, these strategies have been validated in large animal models and clinics via an FDA-approved clinical trial [49]. This case highlights the challenges faced in using tissue-engineered vascular grafts. It demonstrates the effective solutions developed, underscoring this innovative technology's continued promise and potential.
Using quantitative analysis, the biocompatibility of Freeze-cast tissue scaffolds was tested for several materials in mice. The freeze-cast method is versatile in creating porous and structured scaffolds. In the quantitative analysis, measurements were taken for encapsulation thickness, leukocyte cell counts, and density (of the scaffolds). Furthermore, researchers did lymphocyte assays, counting the number of capillaries and histological scoring. All of these methods were used to grade the biocompatibility of the scaffolds based on the cell-matrix and cell-cell interactions [50]. All of these scaffolds were derived from natural sources, and some had chemical modifications on top of them. In-vivo biocompatibility was tested using mice, and all showed to be biocompatible. However, some differed in histopathological responses. This study outlines future directions and suggests a focus on systematically investigating the effects of composition and processing parameters on the response to the scaffold [50].

5. Importance of Continued Innovation in Scaffold Development Using Smart Materials

The case studies reviewed underscore the ongoing need for innovation in scaffold development [49]. The TEVG example demonstrates that overcoming clinical challenges such as stenosis requires a multidisciplinary approach, integrating insights from small and large animal models, computational simulations, and clinical trials [49]. The continued promise of tissue-engineered scaffolds in regenerative medicine highlights the importance of sustained research and development efforts. By addressing current limitations and exploring new materials and techniques, the field can advance toward creating effective, biocompatible scaffolds for various tissue engineering applications.
The field of TE has made substantial progress in developing scaffolds that support tissue regeneration. Advances in materials science and fabrication technologies have enabled the creation of scaffolds that closely mimic the complex structures of natural tissues. Despite these advancements, challenges remain, particularly in achieving consistent biocompatibility and mechanical properties while managing cost and scalability. A suitable TE product should be non-toxic to cells, maintain cell proliferation and differentiation, control antimicrobial activities, and possess electrical stimulation properties both in vitro and in vivo [51]. Owing to the excellent biological and physicochemical characteristics, functionalized MXene exhibits biocompatibility, low toxicity, antibacterial activity, and electrical stimuli, as well as high surface area and hydrophilicity [52]. MXene-incorporated nanocomposites of the various nanostructured membranes, scaffolds, nanofiber, polymer-based microspheres, and 3D-printed devices can be fabricated using different techniques [51]. There is an enormous and unexplored possibility of functionalized MXene nanosheets and MXene-incorporated nanocomposites for TE applications. Biocompatibility, elevated targeting capacity, selectivity, stability, and controlled release behaviors of MXene-based constructs are needed for TE applications.

6. Tissue Engineering and the Use of Nanomaterials

As TE is a field within bioengineering that applies cells, materials, and engineering methods to create or repair tissues and organs, accomplishing the primary goal of creating and repairing tissues is crucial in addressing issues such as organ shortages, tissue damage, and disease. A key obstacle in tissue engineering is the creation of tissues that can mimic the function and microenvironments of native tissues. This challenge stems from the fact that complex tissue structures have specific biochemical, physical, and mechanical properties and are difficult to replicate in tissues grown in a lab. The innovative use of nanomaterials in tissue engineering has the potential to address this limitation. Nanomaterials are chemical substances or materials with nanoscale dimensions. These materials are favorable because they can interact with biological systems in a controlled manner and on a small scale. With nanomaterials, scientists can design scaffolds that can support cells and guide cellular behavior in ways that resemble a natural tissue environment. While nanomaterials have been used in tissue engineering for over two decades, their full potential in this field remains unknown [53].
Further research is needed to understand and optimize the use of nanomaterials in different tissue types, whether it be soft tissue-like skin or rigid skin. The full potential of nanomaterials can be used to mimic the structure of native tissues by fine-tuning the properties of these nanomaterials, such as shape, structure, and size. Nanomaterials can mimic tissue structures because biological tissues comprise nanoscale components such as proteins, lipids, and other molecules that comprise the extracellular matrix (ECM).
The ECM is responsible for providing structural support for cells and has a critical role in cell signaling. We have proper cell growth, migration, and differentiation with the ECM. Therefore, we must create scaffolds that can truly replicate the ECM, as it is vital to the success of engineered tissues. This property significantly bridges the gap between tissues created in vivo and in vitro. Furthermore, nanomaterials such as nanoparticles demonstrate toughness and a high surface area to volume. These two properties are essential for tissue engineering because they allow nanomaterials to withstand the mechanical stress and exchange of substances that engineered tissues experience in vivo. These properties are also important in facilitating cell-matrix interactions and cell proliferation. For example, gold nanoparticles (GNPs) and titanium dioxide nanoparticles have enhanced cell proliferation rates in bone and cardiac tissue [54].
Nanoparticles are only one of a variety of nanomaterials that have been used in tissue engineering. Each type of nanomaterial has its unique properties that make it suitable for different applications. By understanding the strengths of each material, researchers can choose the most appropriate one for the specific tissue they are engineering. Other nanomaterials, such as nanofibers, nanocomposites, and nanotubes, have also proven useful. Nanoparticles are a specific type of nanomaterial, typically spherical, and they possess at least one dimension within the nanoscale range. They are often used in drug delivery, imaging, and diagnostic applications. Their small size allows for precise delivery of drugs or biomolecules to specific areas within the body, which is particularly useful in targeted therapies for tissue regeneration. Due to their small size and high surface area, nanoparticles are ideal for tissue engineering applications [55,56]. This high surface area enhances their interaction with cells, making nanomaterials more effective at promoting cell attachment and growth than larger-scale materials. Nanofibers mimic the architecture of natural tissues and enhance the scope of scaffold fabrication. The ability to closely resemble the fibrous structure of the extracellular matrix makes nanofibers particularly useful in creating scaffolds that support the growth of various cell types. Their structure allows for a highly porous network, facilitating the exchange of nutrients and waste products between the cells and their environment. These fibers exhibit a high surface area to volume ratio, which is essential for the absorptive function of tissues.
Additionally, nanofibers have a microporous structure that benefits tissue engineering [57]. The porosity of these fibers allows for better cell infiltration, which is necessary to integrate engineered tissues with the surrounding native tissues once implanted.
Nanocomposites are composed of a combination of different nanomaterials, allowing them to have a broader range of properties than pure nanomaterials. By combining different materials, nanocomposites can achieve a balance of properties such as mechanical strength, flexibility, and bioactivity, making them more versatile for use in various tissue engineering applications. For instance, nanocomposites can be designed to simultaneously provide MR imaging contrast and allow for drug delivery, combining the best properties of both materials [58]. This multifunctionality is valuable in applications where the progress of tissue regeneration needs to be monitored in real time, as it allows for both therapeutic and diagnostic functions in a single scaffold. Carbon nanotubes (CNTs) are especially useful in tissue engineering scaffolds. They can modify tissues' mechanical strength, conductivity, degradation, and biocompatibility. The ability to fine-tune these properties makes CNTs adaptable to various tissue types, from soft tissues like nerve cells to hard tissues like bone. Furthermore, CNTs can be adjusted to meet the specific requirements of different tissues, making them highly versatile in tissue engineering applications [59]. Their flexibility in design means that CNTs can be engineered to provide the exact mechanical and electrical properties needed for different types of tissues,

7. Future Research Directions

Future research should refine scaffold materials to enhance biocompatibility and mechanical properties while reducing immune responses [60,61]. Continued exploration of advanced fabrication techniques, such as integrating 3D printing, 4D printing, and electrospinning, will be crucial for creating more intricate and functional scaffolds [44,45,62,63,64,65,66]. Additionally, understanding the biological mechanisms underlying scaffold-tissue interactions will be essential for optimizing scaffold designs. Research should also aim to develop scalable and cost-effective production methods to facilitate widespread clinical application.
Conductive polymers with remarkable biocompatibility have been researched and used in various biomedical applications [66]. Due to its properties of high electrical conductivity and chemical stability, poly(3,4-ethylenedioxythiophene) (PEDOT) is currently being used in biomedicine and biotechnology. The copolymer of PEDOT with poly(4-styrene sulfonate) (PSS) has good stability, and the PEDOT: PSS is hydrophilic and holds conductivity properties. The electrochemical, thermal, and oxidative stability of PEDOT: PSS is to be used in wide applications in nanocomposites, flexible electrodes, electrochromic displays, and transistors. Positive results showed that conductive polymer scaffolds made from PEDOT: PSS are structurally suitable for bone tissue engineering.
On the other hand, the conductive nature of the conducting polymer will allow the cells or tissues cultured upon them to be stimulated [66,67]. Composites are developed by blending conductive polymers with other polymers or materials. Modifying conductive polymers can render these polymers biodegradable and biocompatible, making them very useful in TE applications. Applications of conductive polymers are significant concerns. Due to the toxicity and biocompatibility, extensive studies are still required to apply conductive polymers in tissue regeneration and biomedical devices. Cell-conductive polymer-biomolecule-based scaffold biointerfaces should address the insight of cell interaction with conductive materials. The appropriate knowledge will thus help researchers aim for innovative biomaterials for tissue engineering applications.

8. Conclusions

This review highlights several biomaterials-based scaffolds' significant contributions to TE and regenerative medicine by providing an overview of existing literature, key findings, and a review of the highlights and the critical importance of the compatibility of biopolymer scaffolds in providing regenerative improvement to damaged organs. This review identifies the essential findings, highlights them, and contextualizes them within a broader aspect of the research. Innovations in scaffold materials, including natural, synthetic, and composite options, offer distinct advantages and challenges. In TE applications, the nanomaterials not only support the physical structure of the tissue but also interact with cells to promote faster and more efficient tissue regeneration. The choice of fabrication techniques, from traditional methods like solvent casting and gas foaming to advanced techniques such as 3D printing and electrospinning, significantly impacts scaffolds' efficiency, cost, and suitability for various tissues. From the diverse array of biomaterials utilized in scaffold fabrication to exploring their essential qualities, such as structural integrity and biological properties, this review provides an understanding of the vital role of bio and nano materials impact on fabricating scaffolds for TE.

Author Contributions

Conceptualization, N. S..; methodology, NS, A. C., and FS; writing—original draft preparation, NS, AC, and F. S; writing—review and editing, NS; supervision, NS; funding acquisition, NS. All authors have read and agreed to the published version of the manuscript.

Acknowledgments

Authors acknowledge Mim Mim Lim's scholarly contributions, Undergraduate Medical Academy, and Prairie View A&M University's support.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Garot C, Bettega G, Picart C. Additive Manufacturing of Material Scaffolds for Bone Regeneration: Toward Application in the Clinics. Adv Funct Mater. 2020 Oct 15;31(5):2006967. [CrossRef] [PubMed] [PubMed Central]
  2. Aldana AA, Abraham GA. Current advances in electrospun gelatin-based scaffolds for tissue engineering applications. Int J Pharm. 2017 May 25;523(2):441-453. [CrossRef] [PubMed]
  3. Gregor A, Filová E, Novák M, Kronek J, Chlup H, Buzgo M, Blahnová V, Lukášová V, Bartoš M, Nečas A, Hošek J. Designing of PLA scaffolds for bone tissue replacement fabricated by ordinary commercial 3D printer. J Biol Eng. 2017 Oct 16;11:31. [CrossRef] [PubMed] [PubMed Central]
  4. Mao AS, Mooney DJ. Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14452-9. [CrossRef] [PubMed] [PubMed Central]
  5. Dzobo K, Thomford NE, Senthebane DA, Shipanga H, Rowe A, Dandara C, Pillay M, Motaung KSCM. Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine. Stem Cells Int. 2018 Jul 30;2018:2495848. [CrossRef] [PubMed] [PubMed Central]
  6. Kaul H, Ventikos Y. On the genealogy of tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2015 Apr;21(2):203-17. [CrossRef] [PubMed] [PubMed Central]
  7. Krishani M, Shin WY, Suhaimi H, Sambudi NS. Development of Scaffolds from Bio-Based Natural Materials for Tissue Regeneration Applications: A Review. Gels. 2023 Jan 23;9(2):100. [CrossRef] [PubMed] [PubMed Central]
  8. Marques CF, Diogo GS, Pina S, Oliveira JM, Silva TH, Reis RL. Collagen-based bioinks for complex tissue engineering applications: a comprehensive review. J Mater Sci Mater Med. 2019 Mar 6;30(3):32. [CrossRef] [PubMed]
  9. Silver, F. H., Jaffe, M., & Shah, R. G. Structure and behavior of collagen fibers. In Handbook of Properties of Textile and technical fibers (pp. 345–365). 2018. Woodhead Publishing.
  10. Fan, J.; Abedi-Dorcheh, K.; Sadat Vaziri, A.; Kazemi-Aghdam, F.; Rafieyan, S.; Sohrabinejad, M.; Ghorbani, M.; Rastegar Adib, F.; Ghasemi, Z.; Klavins, K.; et al. A Review of Recent Advances in Natural Polymer-Based Scaffolds for Musculoskeletal Tissue Engineering. Polymers 2022, 14, 2097. [Google Scholar] [CrossRef]
  11. Afewerki S, Sheikhi A, Kannan S, Ahadian S, Khademhosseini A. Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics. Bioeng Transl Med. 2018 Dec 28;4(1):96-115. [CrossRef] [PubMed] [PubMed Central]
  12. Kuttappan S, Mathew D, Nair MB. Biomimetic composite scaffolds containing bioceramics and collagen/gelatin for bone tissue engineering - A mini-review. Int J Biol Macromol. 2016 Dec;93(Pt B):1390-1401. [CrossRef] [PubMed]
  13. Lavanya K, Chandran SV, Balagangadharan K, Selvamurugan N. Temperature- and pH-responsive chitosan-based injectable hydrogels for bone tissue engineering. Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110862. [CrossRef] [PubMed]
  14. Islam, S., Bhuiyan, M.A.R. & Islam, M.N. Chitin and Chitosan: Structure, Properties and Applications in Biomedical Engineering. J Polym Environ 25, 854–866 (2017).
  15. Ahmed S, Annu, Ali A, Sheikh J. A review on chitosan-centred scaffolds and their applications in tissue engineering. Int J Biol Macromol. 2018 Sep;116:849-862. [CrossRef] [PubMed]
  16. Cen, L., Liu, W., Cui, L. et al. Collagen Tissue Engineering: Development of Novel Biomaterials and Applications. Pediatr Res 63, 492–496 (2008). [CrossRef]
  17. Gholap AD, Rojekar S, Kapare HS, Vishwakarma N, Raikwar S, Garkal A, Mehta TA, Jadhav H, Prajapati MK, Annapure U. Chitosan scaffolds: Expanding horizons in biomedical applications. Carbohydr Polym. 2024 Jan 1;323:121394.
  18. Echave, M. C., Pimenta-Lopes, C., Pedraz, J. L., Mehrali, M., Dolatshahi-Pirouz, A., Ventura, F., & Orive, G. Enzymatic crosslinked gelatin 3D scaffolds for bone tissue engineering. Int J Pharmaceutics, 2019. 562, 151-161.
  19. Dong C, Lv Y. Application of Collagen Scaffold in Tissue Engineering: Recent Advances and New Perspectives. Polymers (Basel). 2016 Feb 4;8(2):42.
  20. Eivazzadeh-Keihan, R., Noruzi, E. B., Mehrban, S. F., Aliabadi, H. A. M., Karimi, M., Mohammadi, A., & Maleki, A. Review: the latest advances in biomedical applications of chitosan hydrogel as a robust natural structure with eye-catching biological properties. J Mater Sci, 2022 57(6), 3855.
  21. Wong, S. K., Yee, M. M. F., Chin, K.-Y., & Ima-Nirwana, S. A review of the application of natural and synthetic scaffolds in bone regeneration. J Func Biomater, 2023, 14(5), 286. [CrossRef]
  22. Sowmya, S., Bumgardener, J. D., Chennazhi, K. P., Nair, S. V., & Jayakumar, R. (2013). Role of nanostructured biopolymers and bioceramics in enamel, dentin and periodontal tissue regeneration. Progress in Polymer Science, 38(10-11), 1748–1772.
  23. Prabhakaran, M. P., Venugopal, J., Chan, C. K., & Ramakrishna, S. (2008). Surface modified electrospun nanofibrous scaffolds for nerve tissue engineering. Nanotechnology, 19(45), 455102.
  24. Turnbull, G., Clarke, J., Picard, F., Riches, P., Jia, L., Han, F., Li, B., & Shu, W. 3D bioactive composite scaffolds for bone tissue engineering. Bioactive Materials, 2018, 3(3), 278–314. [CrossRef]
  25. Gang, F., Ye, W., Ma, C., Wang, W., Xiao, Y., Liu, C., & Sun, X. 3D printing of PLLA/biomineral composite bone tissue engineering scaffolds. Materials, 2023, 15(12), 4280. [CrossRef]
  26. Kaviani, M., Geramizadeh, B. Basic Aspects of Skin Tissue Engineering: Cells, Biomaterials, Scaffold Fabrication Techniques, and Signaling Factors. J. Med. Biol. Eng. 43, 508–521 (2023).
  27. Kundu, J., Pati, F., Shim, J., & Cho, D. Rapid prototyping technology for bone regeneration. Rapid Prototyping of Biomaterials (Second Edition), 2014, 289-314.
  28. Joseph, B., Jose, C., Kavil, S. V., Kalarikkal, N. & Thomas, S. in Functional Biomaterials: Design and Development for Biotechnology, Pharmacology, and Biomedicine, 2 Volumes 371–394 (wiley, 2023).
  29. Capuana E, Lopresti F, Carfì Pavia F, Brucato V, La Carrubba V. Solution-Based Processing for Scaffold Fabrication in Tissue Engineering Applications: A Brief Review. Polymers (Basel). 2021 Jun 22;13(13):2041. [CrossRef] [PubMed] [PubMed Central]
  30. Sultana, N., Wang, M. Fabrication of HA/PHBV composite scaffolds through the emulsion freezing/freeze-drying process and characterization of the scaffolds. J Mater Sci: Mater Med. 2008, 19, 2555–2561. [CrossRef]
  31. Ejiohuo, O. A Perspective on the Synergistic Use of 3D Printing and Electrospinning to Improve Nanomaterials for Biomedical Applications. Nano Trends, 2023,100025.
  32. El-Fiqi, A., Lee, J. H., Lee, E. J., & Kim, H. W. Collagen hydrogels incorporated with surface-aminated mesoporous nano bioactive glass: improved physicochemical stability and mechanical properties are adequate for complex tissue engineering. Acta Biomater, 2023, 9(12), 9508-9521.
  33. Lim, M. M., Sun, T, Sultana, N. In Vitro Biological Evaluation of Electrospun Polycaprolactone/Gelatine Nanofibrous Scaffold for Tissue Engineering, J Nanomater, 2015, vol. 2015, Article ID 303426, 10 pages, 2015. [CrossRef]
  34. Alshammari, A., Alabdah, F., Wang, W., & Cooper, G. Virtual Design of 3D-Printed Bone Tissue Engineered Scaffold Shape Using Mechanobiological Modeling: Relationship of Scaffold Pore Architecture to Bone Tissue Formation. Polymers, 2023, 15(19), 3918.
  35. Soliman, S., Pagliari, S., Rinaldi, A., Forte, G., Fiaccavento, R., Pagliari, F., … Traversa, E. (2010). Multiscale three-dimensional scaffolds for soft tissue engineering via multimodal electrospinning. Acta Biomaterialia, 6(4), 1227–1237.
  36. Subramanian, A., Krishnan, U. M., & Sethuraman, S. (2011). Fabrication of uniaxially aligned 3D electrospun scaffolds for neural regeneration. Biomedical Materials, 6(2), 025004.
  37. Sun, B., Long, Y. Z., Zhang, H. D., Li, M. M., Duvail, J. L., Jiang, X. Y., & Yin, H. L. (2014). Advances in three-dimensional nanofibrous macrostructures via electrospinning. Progress in Polymer Science, 39(5), 862–890.
  38. Gao, B., Yang, Q., Zhao, X., Jin, G., Ma, Y., & Xu, F. (2016). 4D Bioprinting for Biomedical Applications. Trends in Biotechnology, 34(9), 746-756. [CrossRef]
  39. Lai, J., Liu, Y., Lu, G., Yung, P., Wang, X., Tuan, R. S., & Li, Z. A. (2024). 4D bioprinting of programmed dynamic tissues. Bioactive Materials, 37, 348-377. [CrossRef]
  40. Yan, S., Zhang, F., Luo,L., Wang, L., Liu, Y., Leng.J., Shape Memory Polymer Composites: 4D Printing, Smart Structures, and Applications. Research. 2023;6:0234. [CrossRef]
  41. Gladman AS, Matsumoto EA, Nuzzo RG, Mahadevan L, Lewis JA. Biomimetic 4D printing. Nat Mater. 2016 Apr;15(4):413-8. [CrossRef] [PubMed]
  42. Ionov, L. (2014). Hydrogel-based actuators: Possibilities and limitations. Materials Today, 17(10), 494-503. [CrossRef]
  43. Tian, X., Liu, T., Yang, C., Wang, Q., & Li, D. (2016). Interface and performance of 3D printed continuous carbon fiber reinforced PLA composites. Composites Part A: Applied Science and Manufacturing, 88, 198-205. [CrossRef]
  44. Lin, C., Liu, L., Liu, Y., & Leng, J. (2022). 4D printing of shape memory polybutylene succinate/polylactic acid (PBS/PLA) and its potential applications. Composite Structures, 279, 114729. [CrossRef]
  45. Wei H, Zhang Q, Yao Y, Liu L, Liu Y, Leng J. Direct-write fabrication of 4D active shape-changing structures based on a shape memory polymer and its nanocomposite. ACS Appl Mater Interfaces. 2017;9(1):876–883.
  46. Cui C, Kim DO, Pack MY, Han B, Han L, Sun Y, Han LH. 4D printing of self-folding and cell-encapsulating 3D microstructures as scaffolds for tissue-engineering applications. Biofabrication. 2020;12(4): Article 045018.
  47. Wang Y, Cui H, Wang Y, Xu C, Esworthy TJ, Hann SY, Boehm M, Shen YL, Mei D, Zhang LG. 4D printed cardiac construct with aligned myofibers and adjustable curvature for myocardial regeneration. ACS Appl Mater Interfaces. 2021;13(11):12746–12758.
  48. Shuai C, Wang Z, Peng S, Shuai Y, Chen Y, Zeng D, Feng P. Water-responsive shape memory thermoplastic polyurethane scaffolds triggered at body temperature for bone defect repair. Mater Chem Front. 2022;6(36):1456–1469.
  49. Zheng X, Zhang P, Fu Z, Meng S, Dai L, Yang H. Applications of nanomaterials in tissue engineering. RSC Adv. 2021 May 26;11(31):19041-19058.
  50. Divakar, P., Moodie, K. L., Demidenko, E., Hoopes, P. J., & Wegst, U. G. Quantitative evaluation of the in vivo biocompatibility and performance of freeze-cast tissue scaffolds. Biomed. Mater., 2020, 15(5), 055003.
  51. Maleki, A., et al., Biomedical Applications of MXene-Integrated Composites: Regenerative Medicine, Infection Therapy, Cancer Treatment, and Biosensing. Advanced Functional Materials, 2022: p. 2203430.
  52. Iravani, S. and R.S. Varma, MXenes and MXene-based materials for tissue engineering and regenerative medicine: recent advances. Materials Advances, 2021. 2(9): p. 2906-2917.
  53. Hasan, A., Morshed, M., Memic, A., Hassan, S., Webster, T. J., & Marei, H. E. S. (2018). Nanoparticles in tissue engineering: Applications, challenges, and prospects. International Journal of Nanomedicine, 13, 5637–5655. [CrossRef]
  54. Khan, I., Saeed, K., & Khan, I. (2019). Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 12(7), 908–931. [CrossRef]
  55. Joudeh, N., & Linke, D. (2022). Nanoparticle classification, physicochemical properties, characterization, and applications: A comprehensive review for biologists. Journal of Nanobiotechnology, 20(262). [CrossRef]
  56. Khan, Y., Sadia, H., Shah, S. Z. A., Khan, M. N., Shah, A. A., Ullah, N., Ullah, M. F., Bibi, H., Bafakeeh, O. T., Ben Khedher, N., Eldin, S. M., Fadhl, B. M., & Khan, M. I. (2022). Classification, synthetic, and characterization approaches to nanoparticles, and their applications in various fields of nanotechnology: A review. Catalysts, 12(11), 1386. [CrossRef]
  57. Vasita, R., & Katti, D. S. (2006). Nanofibers and their applications in tissue engineering. International Journal of Nanomedicine, 1(1), 15–30. [CrossRef]
  58. Bramhill, J., Ross, S., & Ross, G. (2017). Bioactive nanocomposites for tissue repair and regeneration: A review. International Journal of Environmental Research and Public Health, 14(1), 66. [CrossRef]
  59. Bao, L., Cui, X., Mortimer, M., Wang, X., Wu, J., & Chen, C. (2023). The renaissance of one-dimensional carbon nanotubes in tissue engineering. Nano Today, 49, 101784. [CrossRef]
  60. Breuer T, Jimenez M, Humphrey JD, Shinoka T, Breuer CK. Tissue Engineering of Vascular Grafts: A Case Report From Bench to Bedside and Back. Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):399-409.
  61. Antmen, E., Vrana, N. E., & Hasirci, V. The role of biomaterials and scaffolds in immune responses in regenerative medicine: macrophage phenotype modulation by biomaterial properties and scaffold architectures. Biomater. Sci. 2021. 9(24), 8090-8110.
  62. Eltom, A., Zhong, G., & Muhammad, A. Scaffold techniques and designs in tissue engineering functions and purposes: a review. Adv. Mater. Sci. Eng., 2019.
  63. Al-Abduljabbar, A., & Farooq, I. Electrospun polymer nanofibers: Processing, properties, and applications. Polymers, 2022, 15(1), 65. [CrossRef]
  64. Shukla, A., Dasgupta, N., Ranjan, S., Singh, S., & Chidambaram, R. Nanotechnology towards prevention of anemia and osteoporosis: from concept to market. Biotech Biotechnol Equip. 2017, 31(5), 863-879.
  65. Sun, J. L., Jiao, K., Niu, L. N., Jiao, Y., Song, Q., Shen, L. J., & Chen, J. H. Intrafibrillar silicified collagen scaffold modulates monocytes to promote cell homing, angiogenesis, and bone regeneration. Biomaterials, 2017, 113, 203-216.
  66. Sultana, N., Chang, H., Jefferson, S. et al. Application of conductive poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) polymers in potential biomedical engineering. J. Pharm. Investig. 50, 437–444 (2020). [CrossRef]
  67. Chang, H. C., Sun, T., Sultana, N., Lim, M. M., Khan, T. H., & Ismail, A. F. (2016). Conductive PEDOT:PSS coated polylactide (PLA) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) electrospun membranes: Fabrication and characterization. Materials Science and Engineering: C, 61, 396-410. [CrossRef]
Figure 1. Schematic diagram of Tissue Engineering Construct (Created with BioRender.com).
Figure 1. Schematic diagram of Tissue Engineering Construct (Created with BioRender.com).
Preprints 137513 g001
Figure 2. Scanning electron micrograph of pectin/chitosan and Gelatin scaffold fabricated using the technique.
Figure 2. Scanning electron micrograph of pectin/chitosan and Gelatin scaffold fabricated using the technique.
Preprints 137513 g002
Figure 3. Morphology of electrospun composite scaffold and HSF cell growth after three days of culture on Polycaprolactone/Gelatin scaffold (reproduced from [33]).
Figure 3. Morphology of electrospun composite scaffold and HSF cell growth after three days of culture on Polycaprolactone/Gelatin scaffold (reproduced from [33]).
Preprints 137513 g003
Table 1. Applications of some natural polymers in tissue engineering. .
Table 1. Applications of some natural polymers in tissue engineering. .
Natural polymer Structure/method of production Biological properties References
Collagen Fibrillar structure, which contributes to the extracellular scaffolding Promotes regeneration
and angiogenesis of the
bone through monocyte
immunomodulation
[16]
Chitosan It contains an amine group, vital in pH sensitivity and functionality Induces biological activity by showing excellent antimicrobial activity against bacteria [17]
Gelatin Composed of a freeze-dried fiber scaffold Produces a scaffold that is enzymatically crosslinked to enhance bone regeneration. [18]
Collagen Consists of a triple helix chain formed by α chains Offers low immunogenicity, a porous structure, permeability, good biocompatibility, and biodegradability [16]
Collagen Classical fibril-forming collagens, including types I, II, and III collagens Crosslink formation can shield or modify major antigenic sites and, thus, reduce their capacity to interact with antibodies. [19]
Chitosan Semicrystalline biopolymer contains several hydrogen bonds forming functional groups, including amino and hydroxyl groups. The hydrogels are pH-sensitive in aqueous media, so these stimuli-responsive hydrogels are the best choice for drug delivery. [20]
Chitosan Scaffolds, cells, and bio-signals, all together to minimize artificial and cellular environment Cardiovascular tissue engineering [15]
Gelatin In its structure, amino acid sequences such as the arginine-glycine-aspartic acid (RGD) motif improve cell adhesion, differentiation, and proliferation. Obtain different isometric points. [18]
Table 2. A summary of several pectin systems in tissue engineering approach [19].
Table 2. A summary of several pectin systems in tissue engineering approach [19].
Pectin Systems Method Application
Low-methoxyl citrus pectin UV photocrosslinking with peptide crosslinkers (cell-degradable) and adhesive ligands (integrin-specific); lyophilization Skin tissue engineering
Sugar beet pectin (SBP) crosslinked by visible light Applying 405 nm visible light in the presence of tris(bipyridine)ruthenium (II) chloride hexahydrate and sodium persulfate, rapid hydrogenation of SBP was obtained; 3D hydrogel constructs were obtained using 3D bioprinting Promising for liver and other soft tissue engineering
Citrus peel’s pectin crosslinked with (3glycidyloxypropyl)
trimethoxysilane (GPTMS)
Freeze-drying or 3D bioprinting Various tissue regeneration
Pectin/chitin/nano CaCO3 Lyophilization Bone regeneration
Pectin/chitosan Freeze-drying Bone tissue engineering
Pectin/strontium/hydroxyapatite Solution-based chemical technique Bone regeneration
Collagen/polyurethane/pectin Semi-interpenetration process Bone regeneration
Pectin/PVA Freezing–thawing Bone regeneration
Poly(L-lactide-co-ɛ-caprolactone) (PLCA)/pectin Scaffolds functionalized with pectin In vitro and in vivo bone regeneration
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated